<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412024001200492</article-id>
<article-id pub-id-type="doi">10.24245/gom.v92i12.9877</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Resultados clínicos del tratamiento con antibiótico triconjugado en pacientes con corioamnionitis con membranas íntegras: serie de casos]]></article-title>
<article-title xml:lang="en"><![CDATA[Outcomes of the triconjugated antibiotics treatment in chorioamnionitis patients with intact membranes: A cases series.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vernaza León]]></surname>
<given-names><![CDATA[Nazly Julieth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guerrero Marín,]]></surname>
<given-names><![CDATA[María Angelica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paredes Martínez,]]></surname>
<given-names><![CDATA[Jorge Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vélez García]]></surname>
<given-names><![CDATA[María Adelaida]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cubides Munévar]]></surname>
<given-names><![CDATA[Angela Mayerli]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Carrillo]]></surname>
<given-names><![CDATA[Mauricio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Libre Seccional Cali Departamento de Ginecología y Obstetricia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Libre Seccional Cali  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Libre Seccional Cali  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad Libre Seccional Cali  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>92</volume>
<numero>12</numero>
<fpage>492</fpage>
<lpage>500</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412024001200492&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412024001200492&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412024001200492&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO: Describir los desenlaces clínicos de pacientes embarazadas con sospecha de corioamnionitis clínica o subclínica que recibieron tratamiento con ceftriaxona, claritromicina y metronidazol.  MATERIALES Y MÉTODOS: Estudio observacional, descriptivo, tipo serie de casos, llevado a cabo en la Clínica Farallones de Cali, Colombia, en pacientes con embarazo pretérmino, entre las 24 y 34.6 semanas, con sospecha diagnóstica de corioamnionitis. Luego de la sospecha diagnóstica se procedió a la amniocentesis y al estudio citoquímico y cultivo de líquido amniótico y posteriormente se inició el esquema triconjugado de antibióticos administrados simultáneamente durante siete días.  RESULTADOS: Se registraron 12 pacientes, con mediana de edad de 25.5 años con promedio de 30.8 semanas de gestación. Casi todas se clasificaron con corioamnionitis subclínica. Luego de completar los siete días de tratamiento triconjugado se evidenció que las semanas de gestación promedio al finalizar el embarazo fueron 34.6 en 5 pacientes que lograron llegar a las 37 semanas, asociado con un periodo de latencia de 37 días (límite inferior: 7-14 días n: 1; límite superior más de 75 días n: 2) a partir de la sospecha clínica hasta la finalización del embarazo.  CONCLUSIONES: Esta serie de casos deja claro que las pacientes con sospecha de corioamnionitis subclínica, establecida por variables clínicas y bioquímicas básicas de laboratorio y microbiología, que reciben tratamiento con antibiótico triconjugado tienen una evolución satisfactoria del embarazo, con proporción de nacimientos a término aceptable y mínimos desenlaces maternos y perinatales adversos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE: To describe the clinical outcome of pregnant patients with suspected clinical or subclinical chorioamnionitis treated with ceftriaxone, clarithromycin, and metronidazole.  MATERIALS AND METHODS: Observational, descriptive, case-series study conducted at the Farallones Clinic in Cali, Colombia, in patients with preterm pregnancy, between 24 and 34.6 weeks, with diagnostic suspicion of chorioamnionitis. After diagnostic suspicion, amniocentesis, cytochemical examination and culture of amniotic fluid were performed, and then a triconjugated antibiotic regimen was started, administered simultaneously for seven days.  RESULTS: There were 12 patients with a mean age of 25.5 years and a mean gestational age of 30.8 weeks. Almost all were classified as having subclinical chorioamnionitis. After completion of 7 days of triconjugate treatment, the mean gestational week at the end of pregnancy was 34.6 in 5 patients who managed to reach 37 weeks, associated with a latency of 37 days (lower limit: 7-14 days n: 1; upper limit more than 75 days n: 2) from clinical suspicion to the end of pregnancy.  CONCLUSIONS: This case series demonstrates that patients with suspected subclinical chorioamnionitis, established by basic clinical and biochemical laboratory and microbiological variables, who receive treatment with a triconjugate antibiotic have a satisfactory pregnancy outcome, with an acceptable proportion of term births and minimal adverse maternal and perinatal outcomes.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Corioamnionitis]]></kwd>
<kwd lng="es"><![CDATA[líquido amniótico]]></kwd>
<kwd lng="es"><![CDATA[amniocentesis]]></kwd>
<kwd lng="es"><![CDATA[agentes antibacterianos]]></kwd>
<kwd lng="es"><![CDATA[parto a término]]></kwd>
<kwd lng="es"><![CDATA[edad gestacional]]></kwd>
<kwd lng="es"><![CDATA[Colombia]]></kwd>
<kwd lng="en"><![CDATA[Chorioamnionitis]]></kwd>
<kwd lng="en"><![CDATA[Amniotic fluid]]></kwd>
<kwd lng="en"><![CDATA[Amniocentesis]]></kwd>
<kwd lng="en"><![CDATA[Anti-bacterial agents]]></kwd>
<kwd lng="en"><![CDATA[Term birth]]></kwd>
<kwd lng="en"><![CDATA[Gestational age]]></kwd>
<kwd lng="en"><![CDATA[Colombia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sirtori]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Oyarzun]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sabo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>1989</year>
<volume>161</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>817-24</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gomez-Lopez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Panaitescu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Leng]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammasome activation during spontaneous preterm labor with intra-amniotic infection or sterile intra-amniotic inflammation]]></article-title>
<source><![CDATA[Am J Reprod Immunol]]></source>
<year>2018</year>
<volume>80</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[YA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>1998</year>
<volume>179</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1254-60</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2001</year>
<volume>185</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1130-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2020</year>
<volume>135</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e80-97</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chapman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Reveiz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bonfill Cosp]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotic regimens for management of intra-amniotic infection]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2014</year>
<volume>2014</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>CD010976</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lyell]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pullen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fuh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Zamah]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2010</year>
<volume>115</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>344-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martingano]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Renson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rogoff]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Daily gentamicin using ideal body weight demonstrates lower risk of postpartum endometritis and increased chance of successful outcome compared with traditional 8-hour dosing for the treatment of intrapartum chorioamnionitis]]></article-title>
<source><![CDATA[J Matern Fetal Neonatal Med]]></source>
<year>2019</year>
<volume>32</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>3204-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Chaemsaithong]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM]]></article-title>
<source><![CDATA[J Matern Fetal Neonatal Med]]></source>
<year>2016</year>
<volume>29</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>707-20</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Chaemsaithong]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM]]></article-title>
<source><![CDATA[J Matern Fetal Neonatal Med]]></source>
<year>2016</year>
<volume>29</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>2727-37</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2019</year>
<volume>221</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>142.e1-142.e22</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Higgins]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Saade]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Polin]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[William]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a Workshop]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2016</year>
<volume>127</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>426-36</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sarmiento]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Sandoval]]></surname>
<given-names><![CDATA[DK.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parámetros del líquido amniótico para diagnóstico de respuesta inflamatoria en parto pretérmino]]></article-title>
<source><![CDATA[Rev Chil Obstet Ginecol]]></source>
<year>2022</year>
<volume>87</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kachikis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Eckert]]></surname>
<given-names><![CDATA[LO]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Brighton Collaboration Chorioamnionitis Working Group. Chorioamnionitis: Case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2019</year>
<volume>37</volume>
<numero>52</numero>
<issue>52</issue>
<page-range>7610-22</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[SWD]]></given-names>
</name>
<name>
<surname><![CDATA[Neubronner]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Dashraath]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chorioamnionitis: An Update on Diagnostic Evaluation]]></article-title>
<source><![CDATA[Biomedicines]]></source>
<year>2023</year>
<volume>11</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2922</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pongchaikul]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mongkolsuk]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vivithanporn]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genomic analysis of Enterococcus faecium strain RAOG174 associated with acute chorioamnionitis carried antibiotic resistance gene: is it time for precise microbiological identification for appropriate antibiotic use?]]></article-title>
<source><![CDATA[BMC Genomics]]></source>
<year>2023</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>405</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Gallagher]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Beck]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Maternal-fetal inflammation in the placenta and the developmental origins of health and disease]]></article-title>
<source><![CDATA[Front Immunol]]></source>
<year>2020</year>
<volume>11</volume>
<page-range>531543</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berezowsky]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Romano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hochberg]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Krispin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The correlation between placental histology and microbiologic infection in the diagnosis of chorioamnionitis in preterm delivery]]></article-title>
<source><![CDATA[Placenta]]></source>
<year>2022</year>
<volume>128</volume>
<page-range>18-22</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O h]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez-Lopez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Twenty-four percent of patients with clinical chorioamnionitis in preterm gestations have no evidence of either culture-proven intraamniotic infection or intraamniotic inflammation]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2017</year>
<volume>216</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>604.e1-604.e11</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
